ATSG to Webcast its Investor Presentation at the 2020 Stephens Investment Conference

ATSG to Webcast its Investor Presentation at the 2020 Stephens Investment Conference

WILMINGTON, Ohio–(BUSINESS WIRE)–
Air Transport Services Group, Inc. (Nasdaq:ATSG) today announced that it will make a webcast presentation on Wednesday, November 18, 2020, at 8:00 a.m. Eastern time at the virtual 2020 Stephens Investment Conference.

Rich Corrado, president and chief executive officer, and Quint Turner, chief financial officer, will discuss the company’s business model and its strategy as the leading independent provider of converted Boeing 767 freighter aircraft, with a full range of complementary services.

They also will review recent developments, including the company’s third-quarter 2020 financial results, recent Boeing 767 freighter aircraft leasing agreements, and its outlook for additional leases in 2021.

ATSG will offer a live audio webcast of its “fireside chat” discussion with Stephens analyst Jack Atkins via a link on its website, www.atsginc.com. The webcast will be available via the same site for 10 days.

About ATSG

ATSG is a leading provider of aircraft leasing and air cargo transportation and related services to domestic and foreign air carriers and other companies that outsource their air cargo lift requirements. ATSG, through its leasing and airline subsidiaries, is the world’s largest owner and operator of converted Boeing 767 freighter aircraft. Through its principal subsidiaries, including three airlines with separate and distinct U.S. FAA Part 121 Air Carrier certificates, ATSG provides aircraft leasing, air cargo lift, passenger ACMI and charter services, aircraft maintenance services and airport ground services. ATSG’s subsidiaries include ABX Air, Inc.; Airborne Global Solutions, Inc.; Airborne Maintenance and Engineering Services, Inc., including its subsidiary, Pemco World Air Services, Inc.; Air Transport International, Inc.; Cargo Aircraft Management, Inc.; and Omni Air International, LLC. For more information, please see www.atsginc.com.

Quint O. Turner, ATSG Inc. Chief Financial Officer

937-366-2303

KEYWORDS: United States North America Ohio

INDUSTRY KEYWORDS: Air Transport Logistics/Supply Chain Management Transportation Travel Other Transport

MEDIA:

Wells Fargo & Company Declares Cash Dividends on Preferred Stock

Wells Fargo & Company Declares Cash Dividends on Preferred Stock

SAN FRANCISCO–(BUSINESS WIRE)–
Wells Fargo & Company (NYSE: WFC) today announced dividends on 13 series of preferred stock.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201113005593/en/

Financial documents (Photo: Wells Fargo).

Financial documents (Photo: Wells Fargo).

A quarterly cash dividend of $18.75 per share was declared on its 7.50% noncumulative perpetual convertible class A preferred stock, Series L, liquidation preference $1,000 per share, which is traded on the New York Stock Exchange under the symbol “WFCPrL”. The Series L dividend is payable on Dec. 15, 2020, to holders of record as of the close of business on Nov. 30, 2020.

A quarterly cash dividend of $325.00 per share was declared on its 5.20% noncumulative perpetual class A preferred stock, Series N, liquidation preference $25,000 per share. This dividend equals $0.325 per depositary share, each representing a 1/1,000 interest in a share of Series N preferred stock, which is traded on the New York Stock Exchange under the symbol “WFCPrN”. The Series N dividend is payable on Dec. 15, 2020, to holders of record as of the close of business on Nov. 30, 2020.

A quarterly cash dividend of $320.31 per share was declared on its 5.125% noncumulative perpetual class A preferred stock, Series O, liquidation preference $25,000 per share. This dividend equals $0.32031 per depositary share, each representing a 1/1,000 interest in a share of Series O preferred stock, which is traded on the New York Stock Exchange under the symbol “WFCPrO”. The Series O dividend is payable on Dec. 15, 2020, to holders of record as of the close of business on Nov. 30, 2020.

A quarterly cash dividend of $328.13 per share was declared on its 5.25% noncumulative perpetual class A preferred stock, Series P, liquidation preference $25,000 per share. This dividend equals $0.32813 per depositary share, each representing a 1/1,000 interest in a share of Series P preferred stock, which is traded on the New York Stock Exchange under the symbol “WFCPrP”. The Series P dividend is payable on Dec. 15, 2020, to holders of record as of the close of business on Nov. 30, 2020.

A quarterly cash dividend of $365.63 per share was declared on its 5.85% fixed-to-floating, noncumulative perpetual class A preferred stock, Series Q, liquidation preference $25,000 per share. This dividend equals $0.36563 per depositary share, each representing a 1/1,000 interest in a share of Series Q preferred stock, which is traded on the New York Stock Exchange under the symbol “WFCPrQ”. The Series Q dividend is payable on Dec. 15, 2020, to holders of record as of the close of business on Nov. 30, 2020.

A quarterly cash dividend of $414.06 per share was declared on its 6.625% fixed-to-floating, noncumulative perpetual class A preferred stock, Series R, liquidation preference $25,000 per share. This dividend equals $0.41406 per depositary share, each representing a 1/1,000 interest in a share of Series R preferred stock, which is traded on the New York Stock Exchange under the symbol “WFCPrR”. The Series R dividend is payable on Dec. 15, 2020, to holders of record as of the close of business on Nov. 30, 2020.

A quarterly cash dividend of $375.00 per share was declared on its 6.00% noncumulative perpetual class A preferred stock, Series T, liquidation preference $25,000 per share. This dividend equals $0.375 per depositary share, each representing a 1/1,000 interest in a share of Series T preferred stock, which is traded on the New York Stock Exchange under the symbol “WFCPrT”. The Series T dividend is payable on Dec. 15, 2020, to holders of record as of the close of business on Nov. 30, 2020.

A quarterly cash dividend of $375.00 per share was declared on its 6.00% noncumulative perpetual class A preferred stock, Series V, liquidation preference $25,000 per share. This dividend equals $0.375 per depositary share, each representing a 1/1,000 interest in a share of Series V preferred stock, which is traded on the New York Stock Exchange under the symbol “WFCPrV”. The Series V dividend is payable on Dec. 15, 2020, to holders of record as of the close of business on Nov. 30, 2020.

A quarterly cash dividend of $356.25 per share was declared on its 5.70% noncumulative perpetual class A preferred stock, Series W, liquidation preference $25,000 per share. This dividend equals $0.35625 per depositary share, each representing a 1/1,000 interest in a share of Series W preferred stock, which is traded on the New York Stock Exchange under the symbol “WFCPrW”. The Series W dividend is payable on Dec. 15, 2020, to holders of record as of the close of business on Nov. 30, 2020.

A quarterly cash dividend of $343.75 per share was declared on its 5.50% noncumulative perpetual class A preferred stock, Series X, liquidation preference $25,000 per share. This dividend equals $0.34375 per depositary share, each representing a 1/1,000 interest in a share of Series X preferred stock, which is traded on the New York Stock Exchange under the symbol “WFCPrX”. The Series X dividend is payable on Dec. 15, 2020, to holders of record as of the close of business on Nov. 30, 2020.

A quarterly cash dividend of $351.56 per share was declared on its 5.625% noncumulative perpetual class A preferred stock, Series Y, liquidation preference $25,000 per share. This dividend equals $0.35156 per depositary share, each representing a 1/1,000 interest in a share of Series Y preferred stock, which is traded on the New York Stock Exchange under the symbol “WFCPrY”. The Series Y dividend is payable on Dec. 15, 2020, to holders of record as of the close of business on Nov. 30, 2020.

A quarterly cash dividend of $296.88 per share was declared on its 4.75% noncumulative perpetual class A preferred stock, Series Z, liquidation preference $25,000 per share. This dividend equals $0.29688 per depositary share, each representing a 1/1,000 interest in a share of Series Z preferred stock, which is traded on the New York Stock Exchange under the symbol “WFCPrZ”. The Series Z dividend is payable on Dec. 15, 2020, to holders of record as of the close of business on Nov. 30, 2020.

A quarterly cash dividend of $153.40 per share was declared on its 4.70% noncumulative perpetual class A preferred stock, Series AA, liquidation preference $25,000 per share. This dividend equals $0.15340 per depositary share, each representing a 1/1,000 interest in a share of Series AA preferred stock, which is traded on the New York Stock Exchange under the symbol “WFCPrA”. The Series AA dividend is payable on Dec. 15, 2020, to holders of record as of the close of business on Nov. 30, 2020.

About Wells Fargo

Wells Fargo & Company (NYSE: WFC) is a diversified, community-based financial services company with $1.92 trillion in assets. Wells Fargo’s vision is to satisfy our customers’ financial needs and help them succeed financially. Founded in 1852 and headquartered in San Francisco, Wells Fargo provides banking, investment, and mortgage products and services, as well as consumer and commercial finance, through 7,200 locations, more than 13,000 ATMs, the internet (wellsfargo.com), and mobile banking, and has offices in 31 countries and territories to support customers who conduct business in the global economy. Wells Fargo serves one in three households in the United States. Wells Fargo & Company was ranked No. 30 on Fortune’s 2020 rankings of America’s largest corporations.

News Release Category: WF-CF

Media

Ancel Martinez, 415-222-3858

[email protected]

Investor Relations

John Campbell, 415-396-0523

[email protected]

KEYWORDS: United States North America Canada California

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Photo
Photo
Financial documents (Photo: Wells Fargo).

Ford’s Kumar Galhotra to Describe Customer, Company Benefits of Commercial Vehicle Ecosystem at Barclays Automotive Conference Nov. 19

Ford’s Kumar Galhotra to Describe Customer, Company Benefits of Commercial Vehicle Ecosystem at Barclays Automotive Conference Nov. 19

DEARBORN, Mich.–(BUSINESS WIRE)–
Kumar Galhotra, president of Ford’s Americas and International Markets Group, is scheduled to speak at the Barclays Global Automotive Conference on Nov. 19.

Galhotra will provide an update on key launches and will discuss how Ford’s commercial vehicle ecosystem – highlighted by all-electric versions of the E-Transit van, unveiled Nov. 12, and F-150 pickup truck – will deliver new forms of value for customers and drive growth for Ford.

E-Transit is part of a Ford investment in electrification of more than $11.5 billion through 2022. The all-new, all-electric Mustang Mach-E begins arriving later this year, while the all-electric F-150 starts hitting dealers in mid-2022. In North America, Ford is the first full-line automaker to announce plans to produce both an all-electric full-size pickup truck and a full-size van for customers – including fleet owners.

“Ford is North America and Europe’s commercial truck and van leader, so the transition of fleet vehicles to zero emissions, especially for the fast-growing last-mile delivery segment, is critical to achieve our carbon neutrality goal by 2050,” said Jim Farley, Ford president and CEO. “Ford is ready to lead the charge, starting with the all-electric Transit and all-electric F-150 on the way. This is good for the planet and a huge advantage for customers to help lower their operating costs and provide connected fleet management technologies that will help their businesses.”

Galhotra’s presentation will begin at 2:05 p.m. ET and be followed by a question-and-answer session. Webcast information is available here and at shareholder.ford.com.

About Ford Motor Company

Ford Motor Company (NYSE: F) is a global company based in Dearborn, Michigan. The company designs, manufactures, markets and services a full line of Ford cars, trucks, SUVs, electrified vehicles and Lincoln luxury vehicles, provides financial services through Ford Motor Credit Company and is pursuing leadership positions in electrification; mobility solutions, including self-driving services; and connected services. Ford employs approximately 187,000 people worldwide. For more information regarding Ford, its products and Ford Motor Credit Company, please visit corporate.ford.com.

Equity Investment Community:

Lynn Antipas Tyson

914.485.1150

[email protected]

Fixed Income Investment Community:

Karen Rocoff

313.621.0965

[email protected]

Shareholder Inquiries:

1.800.555.5259 or 313.845.8540

[email protected]

Media:

Ford Media Center

[email protected]

KEYWORDS: Michigan United States North America

INDUSTRY KEYWORDS: Alternative Vehicles/Fuels Automotive Manufacturing Manufacturing General Automotive Automotive

MEDIA:

Logo
Logo

Cronos Group Inc. to Present at the Jefferies Virtual West Coast Consumer Conference

TORONTO, Nov. 13, 2020 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at the Jefferies Virtual West Coast Consumer Conference on Tuesday, November 17, 2020 at 1:10 p.m. EST.

The webcast will be available on the Investors section of the Company’s website at ir.thecronosgroup.com/events-presentations.

About Cronos Group Inc.

Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group’s portfolio includes PEACE NATURALS™, a global health and wellness platform, two adult-use brands, COVE™ and Spinach™, and three hemp-derived CBD brands, Lord Jones™, Happy Dance™ and PEACE+™. For more information about Cronos Group and its brands, please visit: www.thecronosgroup.com.

Forward-looking Statements
This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include the Company’s intention to build an international iconic brand portfolio and develop disruptive intellectual property. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 (as amended), the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2020, the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2020, the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2020 and the Company’s definitive proxy statement dated April 28, 2020, all of which have been filed on SEDAR and EDGAR and can be accessed at www.sedar.com and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos Group disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

Cronos Group Contact

Anna Shlimak
Tel: (416) 504-0004
[email protected]

GOGL – Invitation to presentation of Q3 2020 Results

In connection with the release of Golden Ocean’s third quarter 2020 results in the morning (CET) of Thursday, November 19, 2020, a teleconference/webcast will be held as described below:

Teleconference and webcast

A conference call will be held at 03:00 P.M. CET (09:00 A.M. New York Time) on Thursday, November 19, 2020. The presentation will be available for download from the Investor Relations section at www.goldenocean.bm (under “Presentations”) prior to the teleconference/webcast.

In order to listen to the presentation you may do one of the following:

a. Webcast
Click the “Webcast” link on www.goldenocean.bm

b. Conference Call
PARTICIPANTS DIAL IN TELEPHONE NUMBERS

International Dial In/UK Local #: +44 (0) 2071 928000
United Kingdom (toll free): +44 (0) 8003 767922
Norway Toll Free #: 800 518 74
USA #: +1 631-5107-495

Participants will be asked for their full name & Conference ID. The Conference ID is 8433555.

Please download the presentation material from www.goldenocean.bm in order to follow the presentation slides while listening to the conference.

REPLAY DETAILS (available for 7 days)

Replay Access Number: 8433555
International Dial In/UK Local #: +44 (0) 3333 009785
Norway #: +47 21 03 42 35
USA #: +1 917-677-7532

Participant list information required: Full Name & Company

November 13, 2020

Hamilton, Bermuda

This information is subject to the disclosure requirements of section 5-12 of the Norwegian Securities Trading Act.

 

 



CPESN® USA Named Federal Pharmacy Partner for the CDC COVID-19 Vaccination Program

Cary, N.C., Nov. 13, 2020 (GLOBE NEWSWIRE) — CPESN USA, a clinically integrated, nationwide organization of pharmacy networks created to advance community-based pharmacy practice, was announced today as a Federal Pharmacy Partner (Network Administrator) for the CDC COVID-19 Vaccination Program. Click here to see the full announcement from the U.S. Department of Health and Human Services.

“We are humbled to be able to participate in the federal COVID-19 vaccine program, said Troy Trygstad, PharmD, MBA, PhD, executive director with CPESN® USA. “We strongly believe that local pharmacies are trusted and accessible – two critical elements for a successful nationwide campaign to immunize against this pandemic.”

Inclusion in the federal government’s COVID-19 vaccination program would not have been possible without tireless support of the National Community Pharmacists Association (NCPA).

“NCPA continues to the trumpet the important role independent, community-based pharmacies can play in the vaccine effort,” offered Jay Williams, director of marketing and communications for CPESN® USA. “Their role in getting us involved – along with other Federal Pharmacy Partners who represent independent pharmacies – cannot be understated.”

CPESN® Networks continue to expand across the country with 50 local networks in 45 states plus the District of Columbia. These pharmacy providers have emerged and joined the movement to provide patients, physicians, and payers with enhanced medication-use and patient-care services that have been proven to improve patient health and lower costs.

“The COVID-19 pandemic has been life altering for Americans,” said Cody Clifton, PharmD, director of practice transformation and clinical programs for CPESN® USA. “Now, CPESN pharmacies are able to exemplify their trusting relationships with patients in their local communities to take a major step in getting our country back to normal. We believe this is a great opportunity to demonstrate the value of community-based pharmacies!”

About CPESN® USA
CPESN® USA a clinically integrated, nationwide organization of pharmacy networks structured to advance community-based pharmacy practice. They empower community-based pharmacies that are deeply rooted within their community by fostering their ability to provide high quality, patient-centered enhanced services. CPESN® pharmacies integrate with other healthcare providers on the patient’s care team to coordinate medical treatment. The results are better medication adherence, higher patient satisfaction, and lower healthcare costs. You can find CPESN® Networks of pharmacy providers in 45 states across America. To learn more, please visit www.CPESN.com.

# # #



Jay Williams
CPESN USA
614.824.9750
[email protected]

CI Financial Announces Change to Executive Management

CI Financial Announces Change to Executive Management

TORONTO–(BUSINESS WIRE)–CI Financial Corp. (“CI” or the “Company”) (TSX: CIX) today announced that Douglas Jamieson has informed the Company of his intention to resign from his position as CI’s Chief Financial Officer to pursue other opportunities.

Mr. Jamieson and the Company have agreed that he will remain in his current position until an orderly transition of his responsibilities is completed. CI has initiated a search for his successor. Mr. Jamieson’s decision to resign is not the result of any issues or disagreement with the Company on any matter relating to its operations, financial statements, internal controls, policies or practices.

“On behalf of the entire company, I want to thank Doug for his 15 years of service as CI’s Chief Financial Officer,” said Kurt MacAlpine, Chief Executive Officer of CI. “Doug has been an integral part of executive management and a contributing force to our firm’s growth over many years. He has my sincerest gratitude for his dedication and commitment to CI.”

Mr. Jamieson joined CI in 1995 and has held positions that have included President and Chief Financial Officer of CI subsidiary CI Investments Inc. He has been Chief Financial Officer of CI since 2005.

About CI Financial

CI Financial Corp. (TSX: CIX) is an independent company offering global asset management and wealth management advisory services. CI’s primary asset management businesses are CI Global Asset Management and GSFM Pty Ltd., and it operates in wealth management through Assante Wealth Management (Canada) Ltd., CI Private Counsel LP, Aligned Capital Partners Inc., CI Direct Investing (WealthBar Financial Services Inc.), CI Investment Services Inc., Balasa Dinverno Foltz LLC, The Cabana Group, LLC, Congress Wealth Management, LLC, One Capital Management, LLC, and Surevest LLC. Further information is available at www.cifinancial.com.

CI Global Asset Management is a registered business name of CI Investments Inc.

This press release contains forward-looking statements concerning anticipated future events, results, circumstances, performance or expectations with respect to CI Financial Corp. (“CI”) and its products and services, including its business operations, strategy and financial performance and condition. Forward-looking statements are typically identified by words such as “believe”, “expect”, “foresee”, “forecast”, “anticipate”, “intend”, “estimate”, “goal”, “plan” and “project” and similar references to future periods, or conditional verbs such as “will”, “may”, “should”, “could” or “would”. Forward-looking statements in this press release include statements about the transitioning of Mr. Jamieson’s responsibilities as Chief Financial Officer and the timing of his departure from CI. These statements and other forward-looking statements are not historical facts but instead represent management beliefs regarding future events, many of which by their nature are inherently uncertain and beyond management’s control. Although management believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements involve risks and uncertainties. The material factors and assumptions applied in reaching the conclusions contained in these forward-looking statements include that the investment fund industry will remain stable and that interest rates will remain relatively stable. Factors that could cause actual results to differ materially from expectations include, among other things, general economic and market conditions, including interest and foreign exchange rates, global financial markets, changes in government regulations or in tax laws, industry competition, technological developments and other factors described or discussed in CI’s disclosure materials filed with applicable securities regulatory authorities from time to time. The foregoing list is not exhaustive and the reader is cautioned to consider these and other factors carefully and not to place undue reliance on forward-looking statements. Other than as specifically required by applicable law, CI undertakes no obligation to update or alter any forward-looking statement after the date on which it is made, whether to reflect new information, future events or otherwise.

Investor Relations

Jason Weyeneth, CFA

Vice-President, Investor Relations & Strategy

416-681-8779

[email protected]

Media Relations

Canada

Murray Oxby

Vice-President, Communications

416-681-3254

[email protected]

United States

Trevor Davis, Gregory FCA for CI Financial

610-415-1145

[email protected]

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Consulting Banking Professional Services Finance

MEDIA:

Logo
Logo

SLAM Reports Elevated Gold Values From Soil Survey

Menneval Soil Samples Contain Up to 683 PPB Gold

MIRAMICHI, New Brunswick, Nov. 13, 2020 (GLOBE NEWSWIRE) — SLAM Exploration Ltd. (“SLAM” or the “Companyon TSXV: SXL) is pleased to announce results for 282 soil samples collected from the vicinity of Zone 9 where new discoveries of quartz veins No 18 and No 22 with multiple sites of visible gold were recently reported in the Company’s news releases issued October 20, 2020 and October 26, 2020. Zone 9 is located about 600m south of the Maisie gold vein within the Company’s wholly-owned Menneval gold project in northwestern New Brunswick.

The Company collected 281 soils samples at 25m intervals on 8 grid lines spaced 100 metres apart and on an additional line at 50 m spacing in the vicinity of recently discovered gold veins. Elevated levels of gold ranging from 5 to 683 parts per billion (“ppb”) occur in 92 of the samples. These include 79 samples containing gold in the range 5 to 20 ppb and 12 samples with gold in the range 21 to 57 ppb. One sample contains 683 ppb gold at an untested site about 25 m north of Zone 9.

Elevated gold levels in the soil indicate potential for extensions of the Maisie vein system to the west, south and east of the known gold veins in the vicinity of Zone 9. The soil anomalies are open in all 3 directions showing potential to extend further. The gold values are shown in thematic form on the attached map.

The Company received the positive soil results after it had dug trench M20-22 which uncovered vein No 22, a 550m long vein with one section mineralized with limonite, goethite and pyrite over a strike length of 180m and at least one site of visible gold reported. Since then, the Company has continued digging cross trenches and has uncovered a series of en echelon veins extending 800m northeast of vein No 22. This expands the Menneval vein system to an area with a north-south dimension of 1,200 m from the northern tip of the Maisie gold vein to the southern tip of vein No. 22 and an east-west dimension of 1,200 m. The vein system is open to the east of the new vein discoveries.

The Company continues the trenching program to discover veins using an excavator and to collect grab samples of vein material. The current focus is to discover as many veins as possible by a series of cross trenches and by grab sampling to identify the higher grade areas. The Company is currently trenching to test for potential new veins and extensions associated with gold soil anomalies south and west of Zone 9.

Assays are pending on 56 grab samples collected from trenches M20-18 to 22, some containing visible gold as reported October 26, 2020. In addition, 45 samples collected from trenches M20-23 to 33 are being shipped to the lab. Results are still pending from 282 soil samples that may assist the Company in the search.

Following this trenching program, the Company expects a potential resumption of diamond drilling activities to test these new gold occurrences. The exploration program is supported in part by a $30,000 contribution to the Menneval gold project under the New Brunswick Junior Mining Assistance Program. Mike Taylor, President & CEO of SLAM, presented a powerpoint to illustrate these new discoveries on Tuesday, October 27, 2020 at the EMP Zoom Conference hosted by the New Brunswick Department Of Natural Resources And Energy (“NBDNRE”). For information please visit:
https://www2.gnb.ca/content/gnb/en/departments/erd/energy/content/conference/Conf_home.html

The Menneval Project: The Menneval Gold project is now comprised of 480 claim units covering 10,460 hectares located in northwestern New Brunswick. The Company holds a 100% interest in the Menneval claims with the exception of 4 claim units covering 105 hectares that are subject to a 1.5% NSR. The Company can buy down 0.5% of the NSR for $500,000 and it has the right of first refusal on the remaining 1% NSR.


About SLAM Exploration Ltd:

SLAM is a project-generating resource company with a portfolio of precious metal and base metal properties in New Brunswick and Ontario. The Company owns the Menneval Gold project and the Lewis Brook silver project in northern New Brunswick, as well as 5 gold projects located in the vicinity of Clarence Stream where Galway Gold Inc. has reported successful gold drilling results in southern New Brunswick. SLAM also owns the Reserve Creek, Opikeigen and Miminiska gold projects in Ontario. The Company owns a portfolio of base metal properties in the Bathurst Mining Camp (“BMC”) that is subject to an option agreement. SLAM also holds NSR royalties on the Superjack, Nash Creek and Coulee zinc‐lead‐copper‐silver properties in the BMC. Additional information about SLAM and its projects is available at www.slamexploration.com or from SEDAR filings at www.sedar.com. Follow us on twitter @SLAMGold.

QA-QC –
Sampling Procedures

Soil samples were collected by GeoXplore Surveys Inc of Bathurst NB and delivered directly to ALS Geochemistry in Moncton New Brunswick for gold analysis using Au-A23, a fire assay with AAS finish. I


Qualifying Statements:
Mike Taylor P.Geo, President and CEO of SLAM Exploration Ltd., a qualified person as defined by National Instrument 43-101, approves the technical information contained in this news release.

Certain information in this press release may constitute forward-looking information, including statements
that address the Private Placement, the closing of the Private Placement, future production, reserve
potential, exploration and development activities and events or developments that the Company expects.
This information is based on current expectations that are subject to significant risks and uncertainties
that are difficult to predict. Actual results might differ materiall
y from results suggested in any
forward-looking
statements. The Company assumes no obligation to update the forward-looking statements, or to
update the reasons why actual results could differ from those reflected in the forward looking-statements
unless and until required by securities laws applicable to the Company. There are a number of risk
factors that could cause future results to differ materially from those described herein. Information
identifying risks and uncertainties is contained in the Company’s filings with the Canadian securities
regulators, which filings are available at www.sedar.com. Neither the TSXV nor its Regulation Services
Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or
accuracy of this release.

CONTACT INFORMATION:

Mike Taylor, President & CEO
Contact: 506-623-8960 [email protected]

Eugene Beukman, CFO
Contact: 604-687-2038 [email protected]                                 SEDAR: 00012459E

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/dd24f3fb-0cb8-42fb-ba6b-5a1803cecf84



Concerned Shareholders Thank Fellow Shareholders for Support and Implore Management to Respect the Will of Shareholders to Enact Change

Canada NewsWire

TORONTO, Nov. 13, 2020 /CNW/ – Roger Sykes, 1703469 Alberta Ltd., Duke Fu, Green Therapeutics LLC, Jason Dyck, Terry Booth and Lola Ventures Inc. (the “Concerned Shareholders“), each of whom is a shareholder of Australis Capital Inc. (“Australis” or the “Company“) (CSE: AUSA), would like to thank shareholders for the overwhelming support they have received to date and are pleased to announce that the Concerned Shareholders have delivered YELLOW proxies representing in excess of 39% of the issued and outstanding common shares of Australis to management. This level of support for the Concerned Shareholder Nominees represents a resoundingly broad-based desire for meaningful change at Australis.

The Concerned Shareholders encourage the Company’s current management and Board of Directors (the “Incumbents“) to take notice of this irrefutable groundswell of support for the Concerned Shareholders. The time has come for the Incumbents to finally act in the best interest of Australis shareholders. Specifically, the Incumbents are not to try to disenfranchise shareholders by attempting to invalidate any of these votes or use technical maneuvers related to the virtual meeting to prevent YELLOW proxyholders from properly executing online ballots related to the yellow proxies.

Please also visit www.fixaustralis.com and follow us on Twitter @fixaustralis.

SOURCE Concerned Shareholders of Australis Capital Inc.

The i2b2 tranSMART Foundation announces COVID AUTHORS and COVID DATATHON

Foundation advances initiatives in support of COVID-10 research

Wakefield, MA, Nov. 13, 2020 (GLOBE NEWSWIRE) — The i2b2 tranSMART Foundation, a global non-profit open-source foundation advancing the development of clinical and translational research through effective collaboration, has been awarded a grant to support the initial deployment of three key initiatives to advance COVID-19 research.

COVIDAuthors.org is a new website containing searchable online profiles of more than 200,000 researchers who have written scientific articles related to COVID-19. It shows which authors have written articles together and illustrates how scientists from many different disciplines have come together to study this worldwide pandemic. Policy makers can use the website to find experts around the world by research topic or geographic region. Funding agencies can track the impact of their investments into COVID-19 research. Investigators can search for collaborators for new COVID-19 research studies. COVIDAuthors.org is powered by Profiles Research Network Software, which was developed by Harvard Catalyst, Harvard’s Clinical and Translational Science Center (Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541).

The Foundation, in cooperation with the Axiomedix and the Open Source Pharma Foundation, is holding a Datathon on November 18-20, 2020.  This Datathon will focus on collaborative data science to better understand the coronavirus and related SARS and MERS viruses, potentially leading to new scientific knowledge and ultimately improvement in patient care. Publicly available datasets relating to the viruses are available in the tranSMART v19 platform on the Foundation Library server to facilitate collaboration. A suite of data exploration and analysis tools will also be available. Participating data scientists will collaborate to identify potential cross-disease biomarkers to advance our understanding of disease pathophysiology and to inform new therapeutic approaches. Leading scientific software vendors and developers will be available to assist throughout the Datathon. The Datathon will be held virtually using the Zoom conferencing system.  See https://i2b2transmart.org/virtual-datathon-2020.                                                                                    

For more information about these projects and their availability, please see the i2b2 tranSMART website at www.i2b2transmart.org. The  projects received support from a grant from Dell Technologies.

About The i2b2 tranSMART Foundation – The i2b2 tranSMART Foundation is a global non-profit open-source organization focused on realizing the promise of precision medicine.  It provides open-source software and databases representing more than 250 million patient lives to thousands of physicians and scientists worldwide.  Its data and analytics platforms help academic, non-profit, healthcare, government and commercial research communities effectively conduct collaborative research.  The Foundation is headquartered in Wakefield, Massachusetts.  The i2b2 tranSMART Foundation can also be found on the web at www.i2b2tranSMART.org.   

###



Rudy potenzone
i2b2 tranSMART Foundation
4258026952
[email protected]